Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−0.0925 SEK
−77.84 M SEK
6.24 M SEK
378.73 M
About ACARIX AB
Sector
Industry
CEO
Aamir Mahmood
Website
Headquarters
Malmö
Founded
2015
ISIN
SE0009268717
FIGI
BBG00FB2F0X6
Acarix AB is engaged in the provision of medical devices for monitoring Coronary Artery Disease. It develops and commercializes diagnostic tests based on its technology platform CADScor System. The company was founded by Peter Boman Samuelsen, Samuel Schmidt, Weimin Rong and Claus Bo Vöge Christensen in 2009 and is headquartered in Malmo, Sweden.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ACARIX is 0.2750 SEK — it has decreased by −2.48% in the past 24 hours. Watch ACARIX AB stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange ACARIX AB stocks are traded under the ticker ACARIX.
ACARIX stock has risen by 5.16% compared to the previous week, the month change is a −14.06% fall, over the last year ACARIX AB has showed a 53.12% increase.
We've gathered analysts' opinions on ACARIX AB future price: according to them, ACARIX price has a max estimate of 0.45 SEK and a min estimate of 0.45 SEK. Watch ACARIX chart and read a more detailed ACARIX AB stock forecast: see what analysts think of ACARIX AB and suggest that you do with its stocks.
ACARIX reached its all-time high on Dec 27, 2016 with the price of 14.6875 SEK, and its all-time low was 0.1690 SEK and was reached on Dec 2, 2024. View more price dynamics on ACARIX chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ACARIX stock is 7.04% volatile and has beta coefficient of −1.43. Track ACARIX AB stock price on the chart and check out the list of the most volatile stocks — is ACARIX AB there?
Today ACARIX AB has the market capitalization of 292.53 M, it has decreased by −3.78% over the last week.
Yes, you can track ACARIX AB financials in yearly and quarterly reports right on TradingView.
ACARIX AB is going to release the next earnings report on Feb 13, 2025. Keep track of upcoming events with our Earnings Calendar.
ACARIX AB revenue for the last quarter amounts to 1.00 M SEK, despite the estimated figure of 4.50 M SEK. In the next quarter, revenue is expected to reach 2.50 M SEK.
ACARIX net income for the last quarter is −18.57 M SEK, while the quarter before that showed −16.66 M SEK of net income which accounts for −11.48% change. Track more ACARIX AB financial stats to get the full picture.
No, ACARIX doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 14.00 employees. See our rating of the largest employees — is ACARIX AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ACARIX AB EBITDA is −70.22 M SEK, and current EBITDA margin is −1.23 K%. See more stats in ACARIX AB financial statements.
Like other stocks, ACARIX shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ACARIX AB stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ACARIX AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ACARIX AB stock shows the sell signal. See more of ACARIX AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.